GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curaleaf Holdings Inc (OTCPK:CURLF) » Definitions » ROE % Adjusted to Book Value

Curaleaf Holdings (Curaleaf Holdings) ROE % Adjusted to Book Value : -4.83% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Curaleaf Holdings ROE % Adjusted to Book Value?

Curaleaf Holdings's ROE % for the quarter that ended in Mar. 2024 was -18.68%. Curaleaf Holdings's PB Ratio for the quarter that ended in Mar. 2024 was 3.87. Curaleaf Holdings's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -4.83%.


Curaleaf Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for Curaleaf Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curaleaf Holdings ROE % Adjusted to Book Value Chart

Curaleaf Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.18 -1.11 -1.95 -10.13 -8.50

Curaleaf Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.56 -12.43 -10.79 -8.31 -4.83

Competitive Comparison of Curaleaf Holdings's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curaleaf Holdings's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Curaleaf Holdings's ROE % Adjusted to Book Value falls into.



Curaleaf Holdings ROE % Adjusted to Book Value Calculation

Curaleaf Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-24.13% / 2.84
=-8.50%

Curaleaf Holdings's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-18.68% / 3.87
=-4.83%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curaleaf Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Curaleaf Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Curaleaf Holdings (Curaleaf Holdings) Business Description

Traded in Other Exchanges
Address
420 Lexington Avenue, Suite 2035, New York, NY, USA, 10170-0052
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 18 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.